103 related articles for article (PubMed ID: 22066238)
1. [Correction of complement system failure in patients with chronic prostatitis].
Teodorovich OV; Shatokhin MN; Mykolaenko TV; Konoplia AI; Krasnov AV; Mavrin MIu; Meshanin NV
Urologiia; 2011; (4):29-32. PubMed ID: 22066238
[TBL] [Abstract][Full Text] [Related]
2. [Correction of local immunometabolic disturbances combined with chronic prostatitis in prostatic adenoma].
Teodorovich OV; Shatokhin MN; Mal'tsov VN; Konoplia AI; Loktiononv AL; Krasnov AV
Urologiia; 2010; (5):22-6. PubMed ID: 21254636
[TBL] [Abstract][Full Text] [Related]
3. [Efficiency of chronic prostatitis treatment with the use of the progam-apparatus complex KAP-ELM-01 "Andro-Gin"].
Usov OE; Sokolov VV
Voen Med Zh; 2003; 324(4):48-9. PubMed ID: 12825367
[No Abstract] [Full Text] [Related]
4. [Validity of using physical therapy in combined treatment of chronic prostatitis].
Razumov SV; Egorov AA
Urologiia; 2005; (2):42-6. PubMed ID: 15989027
[TBL] [Abstract][Full Text] [Related]
5. [Comparative assessment of conservative treatment of chronic prostatitis with application of complex unit andro-gin].
Golubchikova VA; Alekseev MIa; Sitnikov NV; Kochetov AG; Podgornyĭ VF
Urologiia; 2000; (1):20-4. PubMed ID: 16856455
[TBL] [Abstract][Full Text] [Related]
6. [Effects of immunocorrective therapy on immunological indices in patients with chronic bacterial prostatitis].
Repin EV; Dolgikh VT; Dolgikh TN; Ershov AV; Repina TV
Urologiia; 2011; (6):50-4. PubMed ID: 22448482
[TBL] [Abstract][Full Text] [Related]
7. [Efficacy of magnetolaser therapy of patients with an inflammatory form of chronic abacterial prostatitis].
Kogan MI; Shangichev AV; Belousov II
Urologiia; 2010; (2):42-4. PubMed ID: 20973140
[TBL] [Abstract][Full Text] [Related]
8. [Biologically controlled magnetolaser therapy of chronic abacterial prostatitis].
Shangichev AV
Vopr Kurortol Fizioter Lech Fiz Kult; 2009; (3):37-40. PubMed ID: 19637838
[TBL] [Abstract][Full Text] [Related]
9. Activation of the complement system in normal pregnancy and preeclampsia.
Derzsy Z; Prohászka Z; Rigó J; Füst G; Molvarec A
Mol Immunol; 2010 Apr; 47(7-8):1500-6. PubMed ID: 20181396
[TBL] [Abstract][Full Text] [Related]
10. [Defects in spermatogenesis and their correction in patients with chronic abacterial prostatitis].
Neĭmark AI; Aliev RT; Nozdrachev NA; Kraĭnichenko SV; El'chaninova SA; Zolovkina AG; Popovtseva AV; Bespalova OV
Urologiia; 2008; (1):44, 46-50. PubMed ID: 18649680
[TBL] [Abstract][Full Text] [Related]
11. [Levels of complement components in plasma of onco-hematologic patients with defective hemopoiesis].
Rybakova LP; Tiagotin IV; Ganapiev AA; Moiseev SI; Ushakova EA; Abdulkadyrov KM; Ishchenko AM
Vopr Onkol; 1996; 42(2):63-7. PubMed ID: 8815636
[TBL] [Abstract][Full Text] [Related]
12. [Advantages of the use of Andro-Gin device for treatment of secretory infertility].
Aleksandrov VP; Koren'kov DG; Nikolaeva EV
Urologiia; 2006; (3):71-2, 74. PubMed ID: 16889097
[TBL] [Abstract][Full Text] [Related]
13. [Activation of complement and serial changes of anaphylatoxin (C3a, C5a) in patients for open-heart surgery using a membrane oxygenator].
Mitsuhata H; Enzan K; Hasegawa J; Matumoto S; Matsumoto J; Kurosawa S
Masui; 1992 Feb; 41(2):194-9. PubMed ID: 1552659
[TBL] [Abstract][Full Text] [Related]
14. [Comparative analysis of long-term results of treating chronic prostatis with the use of the Andro-Gin device].
Alekseev MIa; Golubchikov VA
Urologiia; 2002; (1):14-7. PubMed ID: 11877964
[TBL] [Abstract][Full Text] [Related]
15. Generation of human C3a, C4a, and C5a anaphylatoxins by protein A of Staphylococcus aureus and immobilized protein A reagents used in serotherapy of cancer.
Langone JJ; Das C; Bennett D; Terman DS
J Immunol; 1984 Aug; 133(2):1057-63. PubMed ID: 6610702
[TBL] [Abstract][Full Text] [Related]
16. [Efficacy of combined physiotherapeutic methods in complex treatment of patients with chronic infectious urethroprostatitis].
Neĭmark AI; Klepikova II; Aliev RT; Kondrat'eva IuS
Urologiia; 2011; (2):48-52. PubMed ID: 21815458
[TBL] [Abstract][Full Text] [Related]
17. Involvement of complement in psoriasis and atopic dermatitis--measurement of C3a and C5a, C3, C4 and C1 inactivator.
Kapp A; Wokalek H; Schöpf E
Arch Dermatol Res; 1985; 277(5):359-61. PubMed ID: 3875319
[TBL] [Abstract][Full Text] [Related]
18. Complement activation in patients with primary antiphospholipid syndrome.
Oku K; Atsumi T; Bohgaki M; Amengual O; Kataoka H; Horita T; Yasuda S; Koike T
Ann Rheum Dis; 2009 Jun; 68(6):1030-5. PubMed ID: 18625630
[TBL] [Abstract][Full Text] [Related]
19. Complement activation in platelet concentrates is surface-dependent and modulated by the platelets.
Gyongyossy-Issa MI; McLeod E; Devine DV
J Lab Clin Med; 1994 Jun; 123(6):859-68. PubMed ID: 8201264
[TBL] [Abstract][Full Text] [Related]
20. Serum complement levels and severity of sepsis.
Nakae H; Endo S; Inada K; Takakuwa T; Kasai T; Yoshida M
Res Commun Chem Pathol Pharmacol; 1994 May; 84(2):189-95. PubMed ID: 8091004
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
